We report meta-analyses of the association of the MTHFR C677T polymorphism with CHD risk in these unpublished datasets and contrast them with meta-analyses of the published studies of this polymorphism and an updated meta-analysis of the CHD results in the randomized trials of B-vitamins for homocysteine reduction. The gene discussed is MTHFR; the disease is coronary artery disorder.